Generic lenacapavir HIV prevention shot wins US FDA approval
Full story
The FDA approved a generic version of lenacapavir. This injection prevents HIV and is administered twice a year. The approval may help provide lower-cost supplies to countries with low and middle incomes.
The FDA has approved a generic version of lenacapavir, a twice-yearly HIV prevention injection, potentially clearing a regulatory hurdle for lower-cost supplies in low- and middle-income countries.